Toviaz and Red blood cell sedimentation rate increased - a phase IV clinical study of FDA data

Summary:

Red blood cell sedimentation rate increased is reported only by a few people who take Toviaz.

The phase IV clinical study analyzes which people take Toviaz and have Red blood cell sedimentation rate increased. It is created by eHealthMe based on reports of 12,134 people who have side effects while taking Toviaz from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

12,134 people reported to have side effects when taking Toviaz.
Among them, 2 people (0.02%) have Red blood cell sedimentation rate increased.

What is Toviaz?

Toviaz has active ingredients of fesoterodine fumarate. It is often used in urge incontinence. eHealthMe is studying from 12,314 Toviaz users for its effectiveness, alternative drugs and more.

What is Red blood cell sedimentation rate increased?

Red blood cell sedimentation rate increased is found to be associated with 1,562 drugs and 1,037 conditions by eHealthMe.

Number of Toviaz and Red blood cell sedimentation rate increased reports submitted per year:

Could Toviaz cause Red blood cell sedimentation rate increased?

Gender of people who have Red blood cell sedimentation rate increased when taking Toviaz *:

female: 100 %
male: 0.0 %

Age of people who have Red blood cell sedimentation rate increased when taking Toviaz *:

Common drugs people take besides Toviaz *:

Common side effects people have besides Red blood cell sedimentation rate increased *:

C-Reactive Protein Increased: 2 people, 100.00%
Retching (strong involuntary effort to vomit): 1 person, 50.00%
Nausea (feeling of having an urge to vomit): 1 person, 50.00%
Diarrhea: 1 person, 50.00%
Abdominal Discomfort: 1 person, 50.00%

Common conditions people have *:

Thyroid Cancer: 1 person, 50.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 50.00%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 50.00%
Joint Pain: 1 person, 50.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 50.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 50.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 50.00%
Dry Eyes (lack of adequate tears): 1 person, 50.00%
Breathing Difficulty: 1 person, 50.00%
Bladder Disorder: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Toviaz and have Red blood cell sedimentation rate increased?

Check whether Red blood cell sedimentation rate increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Red blood cell sedimentation rate increased and when was it recovered:

Red blood cell sedimentation rate increased in Toviaz

Expand to all the drugs that have ingredients of fesoterodine fumarate:

Red blood cell sedimentation rate increased and drugs with ingredients of fesoterodine fumarate

Alternative drugs to, pros and cons of Toviaz:

Toviaz (12,314 reports)

Common Toviaz side effects:

Browse all side effects of Toviaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Red blood cell sedimentation rate increased treatments and more:

Red blood cell sedimentation rate increased (12,841 reports)

COVID vaccines that are related to Red blood cell sedimentation rate increased:

Common drugs associated with Red blood cell sedimentation rate increased:

All the drugs that are associated with Red blood cell sedimentation rate increased:

Red blood cell sedimentation rate increased (1,562 drugs)

Common conditions associated with Red blood cell sedimentation rate increased:

Rheumatoid arthritis: 4,734 reports
Pain: 680 reports
High blood pressure: 597 reports
Juvenile rheumatoid arthritis: 596 reports
Psoriasis: 538 reports

All the conditions that are associated with Red blood cell sedimentation rate increased:

Red blood cell sedimentation rate increased (1,037 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fesoterodine fumarate (the active ingredients of Toviaz) and Toviaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.